Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727695 | SCV000855038 | pathogenic | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000727695 | SCV001248855 | pathogenic | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV001376321 | SCV001573425 | likely pathogenic | Retinitis pigmentosa 39 | 2021-04-08 | criteria provided, single submitter | research | The USH2A c.3296_3297del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2. Based on this evidence we have classified this variant as Likely pathogenic. |
Genome- |
RCV001376321 | SCV004182358 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001376321 | SCV004208314 | pathogenic | Retinitis pigmentosa 39 | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000727695 | SCV004533360 | pathogenic | not provided | 2023-02-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr1099Argfs*27) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 592698). For these reasons, this variant has been classified as Pathogenic. |